Bode-Böger SM - Search Results

1

High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke.

Worthmann H, Chen S, Martens-Lobenhoffer J, Li N, Deb M, Tryc AB, Goldbecker A, Dong Q, Kielstein JT, Bode-Böger SM, Weissenborn K. Worthmann H, et al. J Atheroscler Thromb. 2011;18(9):753-61. doi: 10.5551/jat.8144. Epub 2011 May 12. J Atheroscler Thromb. 2011. PMID: 21566344 Free article.

2

Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits.

Bode-Böger SM, Böger RH, Kienke S, Junker W, Frölich JC. Bode-Böger SM, et al. Biochem Biophys Res Commun. 1996 Feb 15;219(2):598-603. doi: 10.1006/bbrc.1996.0279. Biochem Biophys Res Commun. 1996. PMID: 8605033

3

Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production.

Böger RH, Bode-Böger SM, Mügge A, Kienke S, Brandes R, Dwenger A, Frölich JC. Böger RH, et al. Atherosclerosis. 1995 Oct;117(2):273-84. doi: 10.1016/0021-9150(95)05582-h. Atherosclerosis. 1995. PMID: 8801873

4

Dietary L-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits.

Böger RH, Bode-Böger SM, Kienke S, Stan AC, Nafe R, Frölich JC. Böger RH, et al. Atherosclerosis. 1998 Jan;136(1):67-77. doi: 10.1016/s0021-9150(97)00183-4. Atherosclerosis. 1998. PMID: 9544733

5

Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms.

Böger RH, Bode-Böger SM, Phivthong-ngam L, Brandes RP, Schwedhelm E, Mügge A, Böhme M, Tsikas D, Frölich JC. Böger RH, et al. Atherosclerosis. 1998 Nov;141(1):31-43. doi: 10.1016/s0021-9150(98)00145-2. Atherosclerosis. 1998. PMID: 9863536

6

Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.

Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC. Kielstein JT, et al. J Am Soc Nephrol. 1999 Mar;10(3):594-600. doi: 10.1681/ASN.V103594. J Am Soc Nephrol. 1999. PMID: 10073610 Clinical Trial.

7

Role of endogenous nitric oxide in circadian blood pressure regulation in healthy humans and in patients with hypertension or atherosclerosis.

Bode-Böger SM, Böger RH, Kielstein JT, Löffler M, Schäffer J, Frölich JC. Bode-Böger SM, et al. J Investig Med. 2000 Mar;48(2):125-32. J Investig Med. 2000. PMID: 10736972

8

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.

Böger RH, Bode-Böger SM, Sydow K, Heistad DD, Lentz SR. Böger RH, et al. Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1557-64. doi: 10.1161/01.atv.20.6.1557. Arterioscler Thromb Vasc Biol. 2000. PMID: 10845872

9

Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.

Böger RH, Bode-Böger SM. Böger RH, et al. Semin Thromb Hemost. 2000;26(5):539-45. doi: 10.1055/s-2000-13210. Semin Thromb Hemost. 2000. PMID: 11129410 Review.

10

Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease.

Kielstein JT, Bode-Böger SM, Frölich JC, Haller H, Böger RH. Kielstein JT, et al. Kidney Int Suppl. 2001 Feb;78:S9-13. doi: 10.1046/j.1523-1755.2001.59780009.x. Kidney Int Suppl. 2001. PMID: 11168975 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters